Cathie Wood's ARK Doubles Down on Ginkgo Bioworks (DNA) as Short Sellers Attack Stock, Buys ~8.3M Shares

Cathie Wood's ARK was a large buyer of Ginkgo Bioworks (NYSE: DNA) on Wednesday as short sellers attacked the stock, calling it a fraud. ARK bought ~8.3 million shares of DNA through two funds (ARKK, ARKG) during the trading session.

In addition to DNA, ARK bought ~581K more shares of UiPath (NASDAQ: PATH), among other purchases on Wednesday.

On the sale side, the firm sold another 63,135 shares of Tesla (NASDAQ: TSLA), among other sales.

Below is a summary of ARK's stock trades on 10/07/21 (trades above highlighted):

You May Also Be Interested In

• Tesla (TSLA) continues to slide, breaks under $150
• Tesla lets go of 300 temporary workers in Germany as layoffs continue
• Ibotta (IBTA) starts trading at $118, price IPO at $88